Start the conversation
I keep track of all the tech stocks to buy that I recommend to you.
The performance… the track record… you see, is very important to me.
For ethical reasons, I can't invest in these stocks myself, but I've got a spreadsheet – in the cloud, naturally – and that helps me keep tabs on how well you all are doing.
I'll catch myself grinning when I see that a stock I've recommended is making a move. And I'll often pump my fist in the air when the stock suddenly soars.
I'm not easy on myself when it comes to losers, either. Folks around Money Map Press will tell you that I fall into quite a funk when one of my picks rolls over and heads south.
I don't track my recommendations just to experience these emotional highs and lows. I do it because I want to make sure we're keeping you all on the road to wealth.
I also do it to add to my knowledge base. Because even after 30 years as an investor, I still have plenty to learn.
As I've gathered knowledge over the years, interestingly enough, I've become more of a "rules-based" investor.
And with good reason.
While I love an interesting story – or a hot new gadget that's powered by the latest technology – I recognize that, in a stock-picking venue, these emotional responses to a stock can disrupt my analysis.
So I set up my rules to divert my attention away from such distractions… and focus it on stocks to buy that will create value and make you rich.
A lot of other experts in this business have the same goal – but that's where our philosophies diverge.
Those other folks don't want to share their methods, insights, or secrets.
I feel differently. While I want to help you build a fortune, I feel that I also have a duty to educate you: From our work together, I want you to learn how to identify some winners on your own.
That's why I've shared my rules-based systems with you: There's my "Five Tools to Turn Choppy Markets to Your Advantage," and, of course, there's also my foundational five-part strategy for building wealth through tech.
Today, I thought I'd check my spreadsheet and pick one stock that we can use as a kind of "mini case study." I'm going to show you how to apply my rules-based "screens" to analyze the stock. And then you'll be able to use this system yourself to identify the hottest tech stocks to buy.
Going forward, we'll be able to use these systems together – keeping you on that road to massive wealth…
Now let's take a look at my easy-to-use strategy…
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.